Skip to main content

A High-throughput, Functional Imaging Platform to Accelerate Drug Discovery

Project description

Novel platform at the service of drug discovery for brain disease

Most techniques for functional imaging either interfere with cellular viability and physiology or provide poor resolution. To address these limitations, scientists of the EU-funded Ima-Go project have investigated the commercial feasibility of a 96-well platform that is label-free, non-invasive and can be used with live human cells for high-quality readouts. The platform uses electrodes to track neuronal activity, offering a novel solution for pharmaceutical companies interested in drug development for brain diseases. The Ima-Go project will further scale this technology to a high-throughput platform required in the drug discovery pipeline and introduce novel biological assays that cannot be performed by current competing technologies.

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

MAXWELL BIOSYSTEMS AG
Address
Albisriederstrasse 253
8047 Zurich
Switzerland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000